Prepatent clinical, pathologic, and serologic changes in dogs infected with Dirofilaria immitis and treated with diethylcarbamazine.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D001167:Arteritis / Q000473:pathology; D004049:Diethylcarbamazine / Q000627:therapeutic use*; D004184:Dirofilariasis / Q000188:drug therapy / Q000473:pathology / Q000662:veterinary*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D005370:Filarioidea / Q000302:isolation & purification; D006386:Hemagglutination Tests; D007279:Injections, Subcutaneous; D008168:Lung / Q000473:pathology; D008297:Male; D011651:Pulmonary Artery / Q000473:pathology
D000906:Antibodies; D004049:Diethylcarbamazine